EGFR and lung cancer: Cheung et al.10found that overexpression of CRKL triggered gefitinib resistance in epidermal growth factor receptor (EGFR)‐mutant cells via actuating AKT signaling and extracellular signal‐regulated kinase in non‐small cell lung cancer.